Methods of detecting and treating vaso-occlusive crisis in sickl

Details Methods of detecting and treating vaso-occlusive crisis in sickl Methods of detecting and treating vaso-occlusive crisis in sickl

1996-01-16

1997-09-23

Millin, Vincent

Surgery

Miscellaneous

Methods

514814, 514815, A61B 1900

Patent

active

056693966

ABSTRACT:
Methods are described for treating sickle cell disease, and in particular, detection and treatment of vaso-occlusive crisis in sickle cell disease. Antibodies are employed which bind competitively and suppress adhesion of sickle erythrocytes to autologous lymphocytes.

REFERENCES:
patent: 4157723 (1979-06-01), Granzow et al.
patent: 4265280 (1981-05-01), Ammann et al.
patent: 4321919 (1982-03-01), Edelson
patent: 4412835 (1983-11-01), Spencer
B. Brown, Hematology: Principles and Procedures, 3rd Edition (1980) (Lea & Febiger, Philadelphia) (pp. 242-243).
R.P. Hebbel and N. Mohandas, "Sickle Cell Adherence," In: Sickle Cell Disease: Basic Principles and Clinical Practice, Chapter 16 (1994) (Raven Press, NY) (pp. 217-230).
R. Hoover et al. "Adhesion of Normal and Sickle Erythrocytes to Endothelial Monolayer Cultures," Blood 54:872 (1979).
R.P. Hebbel and W.J. Miller "Phagocytosis of Sickle Erythrocytes: Immunologic and Oxidative Determinants of Hemolytic Anemia," Blood 64:733 (1984).
C.M. Smith et al. "Pluronic F-68 Reduces the Endothelial Adherence and Improves the Rheology of Liganded Sickle Erythrocytes," Blood 69:1631 (1987).
S. Charache et al. "Effect of Hydroxyurea on the Frequency of Painful Crisis in Sickle Cell Anemia," New Eng. J. Med. 332:1317 (1995).
F. Sanchez-Madrid et al., "Three Distinct Antigens Associated with Human T-Lymphocyte-Mediated Cytolysis: LFA-1, LFA-2, and LFA-3," Proc. Nat. Acad. Sci. 79:7489 (1982).
M.L. Plunkett et al., "Rosetting of Activated Human T-Lymphocytes with Autologous Erythrocytes. Definition of the Receptor and Ligand Molecules as CD2 and Lymphocyte Function-Associated Antigen 3 (LFA-3)," J. Exp. Med. 165:664 (1987).
M.R. van Schravendijk et al., "Normal Human Erythrocytes Express CD36, an Adhesion Molecule of Monocytes, Platelets, and Endothelial Cells," Blood 80:2105 (1992).
D. Sugihara et al., "Thrombospondin Mediates Adherence of CD36+ Sickle Reticulocytes to Endothelial Cells," Blood 80:2634-2642 (1992).
T.M. Wick et al., "Unusually Large von Willebrand Factor Multimers Preferentially Promote Young Sickle and Nonsickle Erythrocyte Adhesion to Endothelial Cells," Am. J. Hematology 42:284-292 (1993).
H.A. Brittain et al., "Thrombospondin From Activated Platelets Promotes Sickle Erythrocyte Adherence to Human Microvascular Endothelium Under Physiologic Flow: A Potential Role for Platelet Activation in Sickle Cell Vaso-Occlusion," Blood 81:2137-2143 (1993).
C.C. Joneckis et al., "Integrin .alpha..sub.4 .beta..sub.1 and Glycoprotein IV (CD36) Are Expressed on Circulating Reticulocytes in Sickle Cell Anemia" Blood 82:3548-3555 (1993).
B.E. Gee and O.S. Platt, "Sickle Cell Reticulocytes Adhere to VCAM-1," Blood 85:268-274 (1995).
M.E. Fabry et al., "A Second Generation Transgenic Mouse Model Expressing Both Hemoglobin S (HbS) and HbS-Antilles Results in Increased Phenotypic Severity," Blood 86: 2419-2428 (1995).
T.M. Wick et al., "Molecular basis of sickle cell-endothelial cell interactions," Curr. Op. Hematology 3:118-124 (1996).

Affiliated with

Also associated with

Rating

Methods of detecting and treating vaso-occlusive crisis in sickl does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of detecting and treating vaso-occlusive crisis in sickl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of detecting and treating vaso-occlusive crisis in sickl will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1935316